WallStreetZenWallStreetZen

NYSE: MD
Pediatrix Medical Group Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Pediatrix Medical Group earnings were $174.8M for the trailing 12 months ending Jun 30, 2026, with 62.6% growth year over year. The latest MD earnings report on Jun 30, 2026 announced Q2 2026 earnings of $39.8M, up 34.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MD reported annual earnings of $165.4M, with -266.9% growth.

MD past earnings growth

How has MD's earnings growth performed historically?

Company
62.6%
Industry
48.81%
Market
91.1%
MD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MD earnings history

Current Revenue
$2.0B
Current Earnings
$174.8M
Current Profit Margin
9%
MD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

MD Return on Equity

Current Company
19.9%
Current Industry
-45.4%
Current Market
28.8%
MD's Return on Equity (19.9%)... subscribe to Premium to read more.
High Return on Equity Performance

MD Return on Assets

Current Company
8.1%
Current Industry
6.7%
MD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MD announces earnings.

MD Return on Capital Employed

Current Company
15.98%
Current Industry
13.2%
MD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MD vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MD$283.42M$174.81M+10.67%$2.13
ADUS$167.37M$105.31M+19.06%$5.79
ASTH$200.00M$40.55M-8.86%$0.83
SGRY$429.10M-$88.60MN/A-$0.69
GRDN$119.19M$65.91MN/A$1.05
View Top Medical Care Facility Stocks

Pediatrix Medical Group Earnings Reports & History FAQ

What were Pediatrix Medical Group's earnings last quarter?

On MD's earnings call on Aug 4, 2026, Pediatrix Medical Group (NYSE: MD) reported Q2 2026 earnings per share (EPS) of $0.50, up 8.7% year over year. Total MD earnings for the quarter were $39.84 million. In the same quarter last year, Pediatrix Medical Group's earnings per share (EPS) was $0.46.

If you're new to stock investing, here's how to buy Pediatrix Medical Group stock.

Is Pediatrix Medical Group profitable or losing money?

As of the last Pediatrix Medical Group earnings report, Pediatrix Medical Group is currently profitable. Pediatrix Medical Group's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $174.81 million, a 59.03% increase year over year.

What was MD's earnings growth in the past year?

As of Pediatrix Medical Group's earnings date in Aug 4, 2026, Pediatrix Medical Group's earnings has grown 62.6% year over year. This is 13.79 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 48.81%. MD earnings in the past year totalled $174.81 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.